Ono Pharmaceutical Co., Ltd.
OPHLFOTCHealthcare● Active
$14.55
+$0.00(+0.00%)
Market Cap$6.8B
P/E Ratio—
52W High$18.67
52W Low$9.33
Ono Pharmaceutical Co., Ltd. (OPHLF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OPHLF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $519.03B | $486.87B | $502.67B | $447.19B | $361.36B |
| Cost of Revenue | $142.61B | $147.95B | $127.13B | $110.06B | $93.51B |
| Gross Profit | $376.42B | $338.92B | $375.55B | $337.13B | $267.85B |
| Gross Margin %(computed) | 72.52% | 69.61% | 74.71% | 75.39% | 74.12% |
| Operating Expenses | |||||
| R&D Expenses | $147.97B | $149.87B | $112.38B | $95.34B | $75.88B |
| G&A Expenses | $0.00B | $91.57B | $73.37B | $68.81B | $62.62B |
| Total Operating Expenses | $272.44B | $279.17B | $212.44B | $184.83B | $152.94B |
| Operating Income | $103.99B | $59.75B | $163.10B | $152.29B | $114.91B |
| Operating Margin %(computed) | 20.03% | 12.27% | 32.45% | 34.06% | 31.80% |
| Interest Income | $3.98B | $4.77B | $4.03B | $2.48B | $2.71B |
| Interest Expense | $3.56B | $5.32B | $0.23B | $0.91B | $0.87B |
| Income Before Tax | $93.24B | $59.33B | $163.73B | $143.53B | $105.03B |
| Income Tax Expense | $22.89B | $9.16B | $35.69B | $30.62B | $24.34B |
| Net Income | $70.21B | $50.05B | $127.98B | $112.72B | $80.52B |
| Net Margin %(computed) | 13.53% | 10.28% | 25.46% | 25.21% | 22.28% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $150.19 | $106.55 | $266.61 | $230.85 | $162.19 |
| Wtd Avg Shares | 0.47B | 0.47B | 0.48B | 0.49B | 0.50B |
| EBITDA | $141.98B | $91.54B | $178.44B | $167.50B | $128.54B |
| EBITDA Margin %(computed) | 27.35% | 18.80% | 35.50% | 37.46% | 35.57% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · JPY · B
Explore more Ono Pharmaceutical Co., Ltd. data
About Ono Pharmaceutical Co., Ltd. (OPHLF) Income Statement
Ono Pharmaceutical Co., Ltd. (OPHLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, OPHLF reported revenue of $519.03B, gross profit of $376.42B (gross margin 72.52%), and net income of $70.21B — a net profit margin of 13.53%.
Frequently asked questions
OPHLF · 4 questionsOno Pharmaceutical Co., Ltd. (OPHLF) reported revenue of $519.03B for 2026, up 6.6% year-over-year.
OPHLF revenueOPHLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09